RESUMEN
The atmospheric correction of satellite images based on radiative transfer calculations is a prerequisite for many remote sensing applications. The software package ATCOR, developed at the German Aerospace Center (DLR), is a versatile atmospheric correction software, capable of processing data acquired by many different optical satellite sensors. Based on this well established algorithm, a new Python-based atmospheric correction software has been developed to generate L2A products of Sentinel-2, Landsat-8, and of new space-based hyperspectral sensors such as DESIS (DLR Earth Sensing Imaging Spectrometer) and EnMAP (Environmental Mapping and Analysis Program). This paper outlines the underlying algorithms of PACO, and presents the validation results by comparing L2A products generated from Sentinel-2 L1C images with in situ (AERONET and RadCalNet) data within VNIR-SWIR spectral wavelengths range.
RESUMEN
Background In hereditary hyperferritinaemia-cataract syndrome (HHCS), single nucleic acid alterations in the ferritin light chain (L-ferritin) iron response element (IRE) constitutively derepress ferritin synthesis, resulting in hyperferritinaemia, L-ferritin deposits in the lens of the eye and early bilateral cataract onset. Methods In this study, six German families with putative HHCS were analysed. Clinical diagnosis of HHCS was based on medical history, evaluation of ferritin serum levels, transferrin saturation and clinical ophthalmological examination. Diagnosis was confirmed by polymerase chain reaction (PCR)-based DNA sequencing of the L-ferritin IRE. Results Genetic analysis of the L-ferritin IRE revealed relevant single nucleic acid alterations in each of the affected families. Variants c.-168G > A, c.-168G > U and c.-167C > U were located in the C-bulge region; and variants c.-161C > U and c.-157G > A were located in the hexanucleotide loop of the L-ferritin IRE. Conclusions Family history of hyperferritinaemia and juvenile cataracts are strong indicators of HHCS. Genetic analysis of the L-ferritin IRE is a straightforward procedure to confirm the diagnosis. Accurate diagnosis of hyperferritinaemia can avoid unnecessary treatment by venesection, and focus attention on early cataract detection in offspring at risk.
Asunto(s)
Apoferritinas/genética , Catarata/congénito , Trastornos del Metabolismo del Hierro/congénito , Adulto , Anciano , Anciano de 80 o más Años , Apoferritinas/análisis , Apoferritinas/sangre , Secuencia de Bases/genética , Catarata/diagnóstico , Catarata/epidemiología , Familia , Femenino , Ferritinas/genética , Pruebas Genéticas/métodos , Alemania/epidemiología , Humanos , Hierro/metabolismo , Trastornos del Metabolismo del Hierro/diagnóstico , Trastornos del Metabolismo del Hierro/epidemiología , Masculino , Persona de Mediana Edad , Mutación/genética , LinajeRESUMEN
Imaging spectrometry from aerial or spaceborne platforms, also known as hyperspectral remote sensing, provides dense sampled and fine structured spectral information for each image pixel, allowing the user to identify and characterize Earth surface materials such as minerals in rocks and soils, vegetation types and stress indicators, and water constituents. The recently launched DLR Earth Sensing Imaging Spectrometer (DESIS) installed on the International Space Station (ISS) closes the long-term gap of sparsely available spaceborne imaging spectrometry data and will be part of the upcoming fleet of such new instruments in orbit. DESIS measures in the spectral range from 400 and 1000 nm with a spectral sampling distance of 2.55 nm and a Full Width Half Maximum (FWHM) of about 3.5 nm. The ground sample distance is 30 m with 1024 pixels across track. In this article, a detailed review is given on the applicability of DESIS data based on the specifics of the instrument, the characteristics of the ISS orbit, and the methods applied to generate products. The various DESIS data products available for users are described with the focus on specific processing steps. The results of the data quality and product validation studies show that top-of-atmosphere radiance, geometrically corrected, and bottom-of-atmosphere reflectance products meet the mission requirements. The limitations of the DESIS data products are also subject to a critical examination.
RESUMEN
The clinical application of hematopoietic stem and progenitor cells (HSPCs) has evolved from a highly experimental stage in the 1980s to a currently clinically established treatment for more than 20,000 patients annually who suffer from hematological malignancies and other severe diseases. Studies in numerous murine models have demonstrated that HSPCs reside in distinct niches within the bone marrow environment. Whereas transplanted HSPCs travel through the bloodstream and home to sites of hematopoiesis, HSPCs can be mobilized from these niches into the blood either physiologically or induced by pharmaceutical drugs. Firstly, this review aims to give a synopsis of milestones defining niches and mobilization pathways for HSPCs, including the identification of several cell types involved such as osteoblasts, adventitial reticular cells, endothelial cells, monocytic cells, and granulocytic cells. The main factors that anchor HSPCs in the niche, and/or induce their quiescence are vascular cell adhesion molecule(VCAM)-1, CD44, hematopoietic growth factors, e.g. stem cell factor (SCF) and FLT3 Ligand, chemokines including CXCL12, growth-regulated protein beta and IL-8, proteases, peptides, and other chemical transmitters such as nucleotides. In the second part of the review, we revise the current understanding of HSPC mobilization. Here, we discuss which mechanisms found to be active in HSPC mobilization correspond to the mechanisms relevant for HSPC interaction with niche cells, but also deal with other mediators and signals that target individual cell types and receptors to mobilize HSPCs. A multitude of questions remain to be addressed for a better understanding of HSPC biology and its implications for therapy, including more comprehensive concepts for regulatory circuits such as calcium homeostasis and parathormone, metabolic regulation such as by leptin, the significance of autonomic nervous system, the consequences of alteration of niches in aged patients, or the identification of more easily accessible markers to better predict the efficiency of HSPC mobilization.
RESUMEN
Clinical relevance of ELISA- and single-antigen bead assay (SAB)-detected pretransplant HLA antibodies (SAB-HLA-Ab) for kidney graft survival was evaluated retrospectively in 197 patients transplanted between 2002 and 2009 at the University Clinic Frankfurt. Having adjusted for retransplantation and delayed graft function, a significantly increased risk for death-censored graft loss was found in patients with pretransplant SAB-HLA-Ab [HR: 4.46; 95% confidence interval (CI): 1.47-13.48; P = 0.008]. The risk for increased graft loss was also significant in patients with pretransplant SAB-HLA-Ab but without SAB-detected donor-specific Ab (SAB-DSA) (HR: 4.91; 95% CI of 1.43-16.991; P = 0.012). ELISA was not sufficient to identify pretransplant immunized patients with an increased risk for graft loss. In immunized patients, graft loss was predominantly present in patients who received transplants with a mismatch on the HLA-DR locus. In conclusion, even if our study is limited due to small sample size, the results show an increased risk for long-term graft loss in patients with pretransplant SAB-HLA, even in the absence of DSA. SAB-HLA-Ab-positive patients, being negative in ELISA or CDC assay, might profit from a well-HLA-DR-matched graft and intensified immunosuppression.
Asunto(s)
Anticuerpos/sangre , Supervivencia de Injerto , Antígenos HLA/inmunología , Trasplante de Riñón , Insuficiencia Renal/cirugía , Adulto , Anciano , Biopsia , Funcionamiento Retardado del Injerto/inmunología , Ensayo de Inmunoadsorción Enzimática , Femenino , Humanos , Inmunización , Inmunosupresores/uso terapéutico , Masculino , Persona de Mediana Edad , Proteinuria/sangre , Insuficiencia Renal/inmunología , Estudios Retrospectivos , Factores de Riesgo , Factores de Tiempo , Donantes de TejidosRESUMEN
BACKGROUND/AIMS: Parathyroid hormone (PTH) derivatives exert pronounced renal and osteoanabolic properties when given intermittently. The current study was performed to assess the pharmacokinetic and pharmacodynamic properties as well as safety of subcutaneously applied PTH-1-37 after repeated dosing in healthy subjects. METHODS: This randomized, double-blind, dose-escalating, placebo and active comparator controlled study was conducted in 33 healthy postmenopausal women. Subjects were allocated to one of five treatment options: 10, 20, or 40 µg PTH-1-37, 20 µg PTH-1-34 or placebo, administered as once daily subcutaneous doses for three days. Plasma drug concentrations and serum levels of endogenous PTH-1-84, and calcium as markers of biological activity were monitored during the treatment. RESULTS: PTH was absorbed rapidly from the subcutaneous tissue with a median tmax of 30 minutes for 20 and 40 µg of PTH-1-37. tmax was 45 minutes for 20 µg PTH-1-34. Elimination half-lives were estimated as 76 ± 34 min and 70 ± 13 min for 20 µg and 40 µg PTH-1-37 (mean ± SD), and 78 ± 34 for 20 µg PTH-1-34. Both PTH fragments (PTH-1-37 and PTH-1-34) increased serum calcium. For PTH-1-37 the effect on serum calcium was dose-dependent. Suppression of endogenous PTH-1-84 was seen after the application of both PTH-1-37 and PTH-1-34. During the study period, the subjects experienced no unexpected or serious adverse events. CONCLUSIONS: PTH-1-37 is rapidly absorbed after s.c. injection, has a short plasma elimination half-life, and does not accumulate during multiple dosing. Biological activity was demonstrated by rising serum calcium and decreasing endogenous PTH-1-84 in blood plasma. The study drugs were well tolerated and safe. Our investigation presents data that PTH-1-37 is an excellent drug candidate for intervening with syndromes of dysregulation of calcium metabolism.
Asunto(s)
Hormona Paratiroidea/farmacocinética , Fragmentos de Péptidos/farmacocinética , Calcio/sangre , Calcio/metabolismo , Trastornos del Metabolismo del Calcio/tratamiento farmacológico , Relación Dosis-Respuesta a Droga , Método Doble Ciego , Femenino , Semivida , Voluntarios Sanos , Humanos , Inyecciones Subcutáneas , Persona de Mediana Edad , Hormona Paratiroidea/administración & dosificación , Hormona Paratiroidea/sangre , Fragmentos de Péptidos/administración & dosificaciónRESUMEN
BACKGROUND: Hematopoietic stem and progenitor cell (HPC) motility is essential for HPC transplantation. The chemokine CXCL12 is key for HPC motility. Further regulators are of interest to improve HPC transplantation and regenerative medicine. Here the impact of the human chemokine CCL15 on HPC motility was investigated. METHODS: CCL15 plasma concentrations were determined during HPC mobilization in humans. Activity of CCL15 on HPCs was investigated in murine assays, including chemotaxis, adhesion, and CFU-A assays, and competitive repopulation assays. RESULTS: During HPC mobilization with granulocyte colony-stimulating factor, blood plasma contains increased concentrations (1.1 ± 0.1 ng/ml) of activated CCL15(27-92) versus 0.4 ± 0.1 ng/ml in controls (p = 0.02). CCL15(27-92) significantly enhanced CXCL12-induced transwell migration of Lin-/Sca1+ HPCs and strengthened shear stress-dependent adhesion to vascular cell adhesion molecule-1 (VCAM-1). CCL15(27-92) dose-dependently reduced the colony size in CFU-A assays performed with murine bone marrow and Lin-/Sca1+ HPCs. CCL15(27-92) did not show a direct impact on cell cycle status of HPCs. In murine repopulation assays, pretreatment of bone marrow with CCL15(27-92) significantly increased competitive repopulation. CONCLUSION: Our results point to a regulation of HPCs by CCL15 by modulating migratory and adhesive properties of HPCs with the potency to improve HPC short-term engraftment in stem cell transplantation.
RESUMEN
Microwave (MW) resonators in Electron Paramagnetic Resonance (EPR) spectroscopy concentrate the MW magnetic field (B1) at the sample and separate the MW electric field from the sample. There are numerous experimental methods in EPR spectroscopy which all impose different requirements on MW resonators (e.g. high or low quality factor, MW conversion, and B1-field homogeneity). Although commercial spectrometers offer standardized MW resonators for a broad application range, newly emerging and highly-specialized research fields push these spectrometers to or beyond their sensitivity limits. Optimizing the MW resonator offers one direct approach to improve the sensitivity. Here we present three low-cost optimization approaches for a commercially available X-band (9-10 GHz) MW resonator for three experimental purposes (continuous-wave (CW), transient and pulse EPR). We obtain enhanced MW conversion factors for all three optimized resonators and higher quality factors for two optimized resonators. The latter is important for CW and transient EPR. Furthermore, we fabricated a resonator which features an extended area of homogeneous B1-field and, hence, improved pulse EPR performance. Our results demonstrate that small changes to a commercial MW resonator can enhance its performance in general or for specific applications.
RESUMEN
An end-to-end sensor simulation is a proper tool for the prediction of the sensor's performance over a range of conditions that cannot be easily measured. In this study, such a tool has been developed that enables the assessment of the optimum spectral resolution configuration of a sensor based on key applications. It employs the spectral molecular absorption and scattering properties of materials that are used for the identification and determination of the abundances of surface and atmospheric constituents and their interdependence on spatial resolution and signal-to-noise ratio as a basis for the detailed design and consolidation of spectral bands for the future Sentinel-2 sensor. The developed tools allow the computation of synthetic Sentinel-2 spectra that form the frame for the subsequent twofold analysis of bands in the atmospheric absorption and window regions. One part of the study comprises the assessment of optimal spatial and spectral resolution configurations for those bands used for atmospheric correction, optimized with regard to the retrieval of aerosols, water vapor, and the detection of cirrus clouds. The second part of the study presents the optimization of thematic bands, mainly driven by the spectral characteristics of vegetation constituents and minerals. The investigation is performed for different wavelength ranges because most remote sensing applications require the use of specific band combinations rather than single bands. The results from the important "red-edge" and the "short-wave infrared" domains are presented. The recommended optimum spectral design predominantly confirms the sensor parameters given by the European Space Agency. The system is capable of retrieving atmospheric and geobiophysical parameters with enhanced quality compared to existing multispectral sensors. Minor spectral changes of single bands are discussed in the context of typical remote sensing applications, supplemented by the recommendation of a few new bands for the next generation of optical Sentinel sensors.
RESUMEN
The CC chemokine CCL14a is constitutively expressed in a large variety of tissues and its inactive proform CCL14a(1-74) circulates in high concentrations in plasma. CCL14a(1-74) is converted into CCL14a(9-74) by the proteases urokinase-type plasminogen activator and plasmin and is a highly active agonist for the chemokine receptors CCR1 and CCR5. In this study, a new CCL14a analog, CCL14a(12-74), was isolated from blood filtrate. To elucidate the functional role of the N terminus, a panel of N-terminally truncated CCL14a analogs were tested on the receptors CCR1 to CCR5 and on the human cytomegalovirus (HCMV)-encoded chemokine receptor US28. The rank order of binding affinity to these receptors and of the activation of CCR1 and CCR5-mediated intracellular Ca(2+) concentration mobilization is CCL14a(6-74)<(7-74)<(8-74)<<(9-74) = (10-74)>>(11-74)>>(12-74). The almost identical affinities of CCL14a(7-74), CCL14a(9-74), and CCL14a(10-74) for the US28 receptor and the inhibition of US28-mediated HIV infection of 293T cells by all of the N-terminally truncated CCL14a analogs support the promiscuous nature of the viral chemokine receptor US28. In high concentrations, CCL14a(12-74) did reveal antagonistic activity on intracellular Ca(2+) concentration mobilization in CCR1- and CCR5-transfected cells, which suggests that truncation of Tyr(11) might be of significance for an efficient inactivation of CCL14a. A putative inactivation pathway of CCL14a(9-74) to CCL14a(12-74) may involve the dipeptidase CD26/dipeptidyl peptidase IV (DPPIV), which generates CCL14a(11-74), and the metalloprotease aminopeptidase N (CD13), which displays the capacity to generate CCL14a(12-74) from CCL14a(11-74). Our results suggest that the activity of CCL14a might be regulated by stringent proteolytic activation and inactivation steps.
Asunto(s)
Quimiocinas CC/metabolismo , Fragmentos de Péptidos/fisiología , Péptido Hidrolasas/metabolismo , Receptores de Quimiocina/metabolismo , Señalización del Calcio , Línea Celular , Citomegalovirus , Dipeptidil Peptidasa 4/metabolismo , Fibrinolisina/metabolismo , Infecciones por VIH/prevención & control , Humanos , Fragmentos de Péptidos/química , Unión Proteica , Receptores CCR1/metabolismo , Receptores CCR5/metabolismo , Activador de Plasminógeno de Tipo Uroquinasa/metabolismo , Proteínas Virales/metabolismoRESUMEN
The transmigration capacity of hematopoietic stem and progenitor cells (HSPC) is characteristically associated with their ability to home to sites of hematopoiesis in the transplanted host, to proliferate, to differentiate, and to successfully repopulate the hematopoietic system of a transplanted host. Stimulating agents shown to induce the transmigration of HSPC were often later identified to play significant roles in mobilization of HSPC or their interaction with niche cells in the hematopoietic microenvironment. Transwell migration assays through microporous membranes have been developed in various forms to determine the migration capacity of HSPC or mesenchymal stromal cells (MSCs) toward chemoattractants. We describe here a method of a multi-well reusable transmigration assay using a small volume and low numbers of HSPC, allowing the simple and reproducible determination of HSPC transmigration capacity which enable researchers to obtain rapid answers at limited costs with high reliability.
Asunto(s)
Técnicas de Cultivo de Célula/métodos , Células Madre Hematopoyéticas/citología , Células Madre Mesenquimatosas/citología , Diferenciación Celular , Movimiento Celular , Proliferación Celular , Quimiotaxis , Humanos , Nicho de Células MadreRESUMEN
Multispectral visible/near-infrared (VNIR) earth observation satellites, e.g., Ikonos, Quickbird, ALOS AVNIR-2, and DMC, usually acquire imagery in a few (3 - 5) spectral bands. Atmospheric correction is a challenging task for these images because the standard methods require at least one shortwave infrared band (around 1.6 or 2.2 µm) or hyperspectral instruments to derive the aerosol optical thickness. New classification metrics for defining cloud, cloud over water, haze, water, and saturation are presented to achieve improvements for an automatic processing system. The background is an ESA contract for the development of a prototype atmospheric processor for the optical payload AVNIR-2 on the ALOS platform.
RESUMEN
The CC chemokine receptor 1 (CCR1) has emerged as a relevant factor contributing to inflammatory diseases such as allergic asthma. Commonly used animal models of allergic airway inflammation, especially murine models, have certain limitations. The elaborate, nonhuman, primate models of asthma display the highest comparability with the situation in humans. These models play an important role in the understanding of the pathogenesis of asthma. To improve the understanding in cynomolgus monkey models, we identified and characterized CCR1 in this nonhuman primate. Initially, we cloned the cynomolgus monkey CCR1 (cCCR1) gene, and the sequence analysis revealed high homology at the nucleotide (92%) and amino acid (88.4%) levels with its human counterpart. Human embryonic kidney 293 cells were stably transfected with cCCR1 and used in functional assays. Among those CCR1 ligands tested, CCL14(9-74) was most potent in the induction of intracellular Ca2+ fluxes as observed for human CCR1 (hCCR1). Complete cross-desensitization could be achieved between CCL14(9-74) and CCL15. However, CCL3 could not fully abrogate the response to the potent ligand CCL14(9-74). Competition-binding studies with radiolabeled CCL3 concordantly showed that CCL14(9-74) has a higher affinity to cCCR1 than hCCL3. Moreover, differential tissue-specific expression of cCCR1 was investigated by real-time quantitative polymerase chain reaction, displaying the highest levels in spleen. This study adds basic information needed for the evaluation of the role of CCR1 in the pathophysiology of asthma using the highly relevant cynomolgus monkey model and in addition, aids in the preclinical evaluation of potential novel drugs targeting CCR1.
Asunto(s)
Regulación de la Expresión Génica , Macaca fascicularis/genética , Receptores de Quimiocina/genética , Receptores de Quimiocina/metabolismo , Secuencia de Aminoácidos , Animales , Unión Competitiva , Línea Celular , Quimiocinas/farmacología , Quimiocinas CC/farmacología , Clonación Molecular , Modelos Animales de Enfermedad , Subunidades alfa de la Proteína de Unión al GTP Gi-Go/genética , Humanos , Ligandos , Ratones , Datos de Secuencia Molecular , Ratas , Receptores CCR1 , Receptores de Quimiocina/efectos de los fármacos , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Homología de Secuencia de Aminoácido , Factores de TiempoRESUMEN
CXCL12-CXCR4 signaling controls multiple physiological processes and its dysregulation is associated with cancers and inflammatory diseases. To discover as-yet-unknown endogenous ligands of CXCR4, we screened a blood-derived peptide library for inhibitors of CXCR4-tropic HIV-1 strains. This approach identified a 16 amino acid fragment of serum albumin as an effective and highly specific CXCR4 antagonist. The endogenous peptide, termed EPI-X4, is evolutionarily conserved and generated from the highly abundant albumin precursor by pH-regulated proteases. EPI-X4 forms an unusual lasso-like structure and antagonizes CXCL12-induced tumor cell migration, mobilizes stem cells, and suppresses inflammatory responses in mice. Furthermore, the peptide is abundant in the urine of patients with inflammatory kidney diseases and may serve as a biomarker. Our results identify EPI-X4 as a key regulator of CXCR4 signaling and introduce proteolysis of an abundant precursor protein as an alternative concept for chemokine receptor regulation.
Asunto(s)
Fragmentos de Péptidos/metabolismo , Péptidos/metabolismo , Receptores CXCR4/antagonistas & inhibidores , Albúmina Sérica/metabolismo , Secuencia de Aminoácidos , Animales , Biomarcadores/orina , Línea Celular , Movimiento Celular/efectos de los fármacos , Células HEK293 , VIH-1/fisiología , Semivida , Humanos , Células Jurkat , Ratones , Ratones Endogámicos C57BL , Datos de Secuencia Molecular , Fragmentos de Péptidos/química , Fragmentos de Péptidos/farmacología , Biblioteca de Péptidos , Péptidos/química , Péptidos/farmacología , Unión Proteica , Estructura Terciaria de Proteína , Receptores CXCR4/metabolismo , Insuficiencia Renal Crónica/metabolismo , Insuficiencia Renal Crónica/patología , Alineación de Secuencia , Albúmina Sérica/química , Albúmina Sérica/farmacología , Transducción de Señal/efectos de los fármacos , Internalización del Virus/efectos de los fármacosRESUMEN
Mobilization of hematopoietic stem and progenitor cells (HPCs) is induced by treatment with granulocyte-colony stimulating factor, chemotherapy, or irradiation. We observed that these treatments are accompanied by a release of chemotactic activity into the blood. This plasma activity is derived from the bone marrow, liver, and spleen and acts on HPCs via the chemokine receptor CXCR4. A human blood peptide library was used to characterize CXCR4-activating compounds. We identified CXCL12[22-88] and N-terminally truncated variants CXCL12[24-88], CXCL12[25-88], CXCL12[27-88], and CXCL12[29-88]. Only CXCL12[22-88] could effectively bind to CXCR4 and induce intracellular calcium flux and chemotactic migration of HPCs. CXCL12[25-88] and CXCL12[27-88] revealed neither agonistic nor antagonistic activities in vitro, whereas CXCL12[29-88] inhibited CXCL12[22-88]-induced chemotactic migration. Since binding to glycosaminoglycans (GAG) modulates the function of CXCL12, binding to heparin was analyzed. Surface plasmon resonance kinetic analysis showed that N-terminal truncation of Arg22-Pro23 increased the dissociation constant KD by one log10 stage ([22-88]: KD: 5.4 ± 2.6 µM; [24-88]: KD: 54 ± 22.4 µM). Further truncation of the N-terminus decreased the KD ([25-88] KD: 30 ± 4.8 µM; [27-88] KD: 23 ± 1.6 µM; [29-88] KD: 19 ± 5.4 µM), indicating increasing competition for heparin binding. Systemic in vivo application of CXCL12[22-88] as well as CXCL12[27-88] or CXCL12[29-88] induced a significant mobilization of HPCs in mice. Our findings indicate that plasma-derived CXCL12 variants may contribute to the regulation of HPC mobilization by modulating the binding of CXCL12[22-88] to GAGs rather than blocking the CXCR4 receptor and, therefore, may have a contributing role in HPC mobilization.
Asunto(s)
Quimiocina CXCL12/sangre , Quimiotaxis , Células Madre Hematopoyéticas/fisiología , Animales , Plaquetas/metabolismo , Señalización del Calcio , Células Cultivadas , Trasplante de Células Madre Hematopoyéticas , Humanos , Leucocitos/metabolismo , Ratones Endogámicos DBA , Unión Proteica , Procesamiento Proteico-Postraduccional , ProteolisisRESUMEN
Intervention on chemokine receptors to prevent directional leukocyte migration is a potential therapeutic strategy. NNY-CCL14 is a CD26-resistant lead molecule, which exerts its effects on multiple chemokine receptors (CCR1, CCR2, CCR3, and CCR5). The inhibitory effects of NNY-CCL14 in murine models of allergic airway inflammation have been assigned to its interaction with CCR1 and CCR5. In this study, a non-GAG-binding variant of NNY-CCL14 was generated by mutating basic amino acids within the identified GAG-binding 49BBXB52 motif. This CD26-resistant, non-GAG binding variant, NNY-CCL14(G,A), does not promote CCR1-dependent cell arrest on modeled endothelium. Its biological activity tested on human and murine chemokine receptors revealed distinguishing properties to NNY-CCL14. As suggested by EC50 values for intracellular calcium mobilization, NNY-CCL14(G,A) demonstrated a reduced ability to activate hCCR1, but internalization and desensitization of hCCR1 were unperturbed. Surprisingly, its activity on hCCR3 was strongly reduced, and it did not internalize mCCR3. A significantly reduced chemotactic activity of eosinophils and monocytes was observed. All biological effects mediated by NNY-CCL14(G,A) via hCCR5 and mCCR5 showed no difference to NNY-CCL14. In mice treated i.v. with NNY-CCL14(G,A), a sustained in vivo down-modulation of CCR5 was achieved over 3 h. Therefore, NNY-CCL14(G,A) inactivates leukocytes by desensitizing and internalizing multiple chemokine receptors, thus rendering them unresponsive to further stimulation by natural ligands. When administered systemically, NNY-CCL14(G,A) may modulate leukocyte functions prior to their interaction with other endothelium-bound chemokines expressed under pathophysiological conditions, such as allergic inflammation.
Asunto(s)
Quimiocinas CC/fisiología , Leucocitos/metabolismo , Mutación , Receptores CCR1/metabolismo , Receptores CCR5/metabolismo , Animales , Señalización del Calcio , Quimiocinas CC/genética , Humanos , Ratones , Mutagénesis , Unión Proteica , Receptores de Quimiocina/metabolismoRESUMEN
One of the initial steps in the preprocessing of remote sensing data is the atmospheric correction of the at-sensor radiance images, i.e., radiances recorded at the sensor aperture. Apart from the accuracy in the estimation of the concentrations of the main atmospheric species, the retrieved surface reflectance is also influenced by the spectral calibration of the sensor, especially in those wavelengths mostly affected by gaseous absorptions. In particular, errors in the surface reflectance appear when a systematic shift in the nominal channel positions occurs. A method to assess the spectral calibration of hyperspectral imaging spectrometers from the acquired imagery is presented in this paper. The fundamental basis of the method is the calculation of the value of the spectral shift that minimizes the error in the estimates of surface reflectance. This is performed by an optimization procedure that minimizes the deviation between a surface reflectance spectrum and a smoothed one resulting from the application of a low-pass filter. A sensitivity analysis was performed using synthetic data generated with the MODTRAN4 radiative transfer code for several values of the spectral shift and the water vapor column content. The error detected in the retrieval is less than +/- 0.2 nm for spectral shifts smaller than 2 nm, and less than +/- 1.0 nm for extreme spectral shifts of 5 nm. A low sensitivity to uncertainties in the estimation of water vapor content was found, which reinforces the robustness of the algorithm. The method was successfully applied to data acquired by different hyperspectral sensors.
RESUMEN
Chemokines are believed to be involved in the pathogenesis of chronic renal failure (CRF). In CRF, significantly increased CCL15-IR plasma concentrations were detected. Whereas in plasma of healthy individuals one predominant CCL15-IR molecule with a M(w) of 15kDa [high molecular weight (HMW-CCL15-IR)] was identified, CRF plasma contains increased concentrations of truncated CCL15-IR molecules [intermediate molecular weight (IMW-CCL15-IR)]. HMW-CCL15-IR isolated from hemofiltrate revealed an M(w) of 10141.3, corresponding to deglycosylated CCL15(1-92) carrying a N-terminal pyrrolidone carboxylic acid. CCL15(12-92) was identified as a major component of IMW-CCL15-IR in CRF plasma. Compared to CCL15(1-92), in monocytes CCL15(12-92) causes stronger induction of intracellular calcium flux, chemotactic activity, and adhesion to fibronectin. Intracellular calcium flux assays revealed that, in comparison to peripheral blood mononuclear cells (PBMC) of healthy donors, PBMCs of CRF patients demonstrated an increased sensitivity to CCL15. Our results point to an involvement of the CCL15-CCR1 axis in the pathophysiology of CRF.
Asunto(s)
Quimiocinas CC/sangre , Fallo Renal Crónico/sangre , Monocinas/sangre , Adulto , Anciano , Anciano de 80 o más Años , Secuencia de Aminoácidos , Calcio/metabolismo , Quimiocinas CC/química , Quimiocinas CC/farmacología , Quimiotaxis/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Femenino , Hemofiltración , Humanos , Fallo Renal Crónico/terapia , Proteínas Inflamatorias de Macrófagos , Masculino , Persona de Mediana Edad , Peso Molecular , Monocitos/citología , Monocitos/efectos de los fármacos , Monocitos/metabolismo , Monocinas/química , Monocinas/farmacología , Fragmentos de Péptidos/farmacología , Diálisis Renal , Espectrometría de Masa por Láser de Matriz Asistida de Ionización DesorciónRESUMEN
Differentiation of adult bone marrow (BM) cells into nonhematopoietic cells is a rare phenomenon. Several reports, however, suggest that human umbilical cord blood (hUCB)-derived cells give rise to hepatocytes after transplantation into nonobese diabetic-severe combined immunodeficient (NOD-SCID) mice. Therefore, we analyzed the hepatic differentiation potential of hUCB cells and compared the frequency of newly formed hepatocyte-like cells in the livers of recipient NOD-SCID mice after transplantation of hUCB versus murine BM cells. Mononuclear cell preparations of hUCB cells or murine BM from enhanced green fluorescent protein transgenic or wild-type mice were transplanted into sublethally irradiated NOD-SCID mice. Liver regeneration was induced by carbon tetrachloride injury with and without subsequent hepatocyte growth factor treatment. By immunohistochemistry and reverse transcriptase-polymerase chain reaction, we detected clusters of hepatocyte-like cells in the livers of hUCB-transplanted mice. These cells expressed human albumin and Hep Par 1 but mouse CK18, suggesting the formation of chimeric hepatocyte-like cells. Native fluorescence microscopy and double immunofluorescence failed to detect single hepatocytes derived from transplanted enhanced green fluorescent protein-transgenic mouse BM. Fluorescent in situ hybridization rarely revealed donor-derived hepatocyte-like cells after cross-gender mouse BM transplantation. Thus, hUCB cells have differentiation capabilities different from murine BM cells after transplantation into NOD-SCID mice, demonstrating the importance of further testing before hUCB cells can be used therapeutically.
Asunto(s)
Diferenciación Celular , Sangre Fetal/citología , Células Madre Hematopoyéticas/citología , Hepatocitos/citología , Queratinas/metabolismo , Hígado/lesiones , Animales , Células de la Médula Ósea/citología , Células de la Médula Ósea/metabolismo , Trasplante de Médula Ósea , Tetracloruro de Carbono/toxicidad , Trasplante de Células Madre de Sangre del Cordón Umbilical , Femenino , Sangre Fetal/metabolismo , Proteínas Fluorescentes Verdes/genética , Proteínas Fluorescentes Verdes/fisiología , Células Madre Hematopoyéticas/metabolismo , Factor de Crecimiento de Hepatocito/farmacología , Hepatocitos/metabolismo , Humanos , Hígado/metabolismo , Regeneración Hepática , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Endogámicos NOD , Ratones SCID , Ratones Transgénicos , Trasplante HeterólogoRESUMEN
Monocyte infiltration into inflammatory sites is generally preceded by neutrophils. We show here that neutrophils may support this process by activation of CCL15, a human chemokine circulating in blood plasma. Neutrophils were found to release CCL15 proteolytic activity in the course of hemofiltration of blood from renal insufficiency patients. Processing of CCL15 immunoreactivity (IR) in the pericellular space is suggested by a lack of proteolytic activity in blood and blood filtrate, but a shift of the retention time (t(R)) of CCL15-IR, detected by chromatographic separation of CCL15-IR in blood and hemofiltrate. CCL15 molecules with N-terminal deletions of 23 (delta23) and 26 (delta26) aa were identified as main proteolytic products in hemofiltrate. Neutrophil cathepsin G was identified as the principal protease to produce delta23 and delta26 CCL15. Also, elastase displays CCL15 proteolytic activity and produces a delta21 isoform. Compared with full-length CCL15, delta23 and delta26 isoforms displayed a significantly increased potency to induce calcium fluxes and chemotactic activity on monocytes and to induce adhesiveness of mononuclear cells to fibronectin. Thus, our findings indicate that activation of monocytes by neutrophils is at least in part induced by quantum proteolytic processing of circulating or endothelium-bound CCL15 by neutrophil cathepsin G.